Other News To Note
Monday, July 11, 2011
Marina Biotech Inc., of Bothell, Wash., said preclinical data showed a miRNA mimetic formulated using its liposomal-based delivery technology, SMARTICLES, demonstrated inhibition of tumor growth in an orthotopic liver tumor, as indicated by a decrease in systemic liver tumor biomarker alpha-feto protein and a decrease in tumor weight of more than 80 percent.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.